Back to Agenda
Why Does Drug Development Need Project Management?
Session Chair(s)
Timothy M. Phelan, PHD
Executive Director, Merck & Co., Inc., United States
Bringing a new medicine to patients is one of the truest examples of project management, yet the business results for large pharmaceuticals suggest we have not fully realized the business benefit of applying project management theory and practice. This session will discuss how maximizing the project management infrastructure already installed in drug development organizations will improve their business results.
Learning Objective : Describe how to drive business results with existing infrastructure; Discuss the balance between the art and science of project management; Explain real-world application.
Speaker(s)
Vanessa Graham, MBA
Executive Director, Global Program Management, Amgen Inc., United States
Panelist
Jim L. Vandergriff
Manager, CTMS Supply Planning, CT Material Supply Chain Planning, Eli Lilly and Company, United States
Panelist
Have an account?